治疗相关肺纤维化患者症状管理自 efficacy 与负担及日常活动能力的关系
Symptom management self efficacy relates to self perceived burden and IADL in lung cancer patients with treatment associated pneumonitis
一项横断面研究显示,140 名接受放疗联合免疫治疗后发生治疗相关肺纤维化的肺癌患者中,症状管理自 efficacy 与负担及日常活动能力呈负相关,调整协变量后,症状管理自 efficacy 分别解释了 20.5% 和 17.5% 的负担和日常活动能力变异。高症状管理自 efficacy 的患者负担较低且日常活动能力较好。
- Article
- Open access
- Published: 06 November 2026
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
To examine symptom management self-efficacy, self-perceived burden, and impairment in instrumental activities of daily living among patients with lung cancer who developed treatment-associated pneumonitis (TAP) after radiotherapy combined with immunotherapy, and to analyze the relationships among these factors. This cross-sectional study included 140 TAP patients from October 2024 to June 2025. Data were collected using the Self-Efficacy for Symptom Management Scale (SESMs), Self-Perceived Burden Scale (SPBS), and Instrumental Activities of Daily Living Scale (IADL). Pearson correlation, group comparisons, and hierarchical regression were performed. Mean SESMs, SPBS, and IADL scores were (6.00 ± 0.38), (34.35 ± 5.00), and (21.04 ± 4.00), respectively. SESMs scores were negatively correlated with SPBS scores (r=-0.663) and IADL scores (r=-0.634) (both P < 0.001); SPBS scores were positively correlated with IADL scores (r = 0.429, P < 0.001). After covariate adjustment, SESMs scores additionally explained 20.5% of the variance in SPBS scores (ΔR² = 0.205) and 17.5% of the variance in IADL scores (ΔR² = 0.175). SPBS and IADL scores jointly explained an additional 21.0% of the variance in SESMs score (ΔR² = 0.210). Among patients with TAP, those with higher symptom management self-efficacy had lower self-perceived burden and less impairment in instrumental activities of daily living.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Shanxi, 030013, China
Fang Zhi
Radiotherapy Department, Shanxi Province Cancer Hospital, No. 3, Zhigong New Street, Xinghualing District, Taiyuan City, 030013, Shanxi Province, China
Jia Fu, LiNa Bai, Xiao Juan Liu, YaLi Sun & XueFeng Huang
Authors
- Fang Zhi
- Jia Fu
- LiNa Bai
- Xiao Juan Liu
- YaLi Sun
- XueFeng Huang
Corresponding author
Correspondence to XueFeng Huang.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study was conducted in strict accordance with the ethical guidelines established by the Declaration of Helsinki. The study protocol has successfully passed the ethical review by the Ethics Committee of Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, and the ethics approval number granted by the committee is [KY2024174]. Throughout the entire research process, from the research design to all aspects of implementation, full consideration has been given to safeguarding the rights, safety, and well-being of the subjects, ensuring compliance with all requirements of ethical standards.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent to publish
The authors affirm that all human participants provided informed consent for the publication of relevant data included in this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zhi, F., Fu, J., Bai, L. et al. Symptom management self efficacy relates to self perceived burden and IADL in lung cancer patients with treatment associated pneumonitis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-76186-5
Received: 30 March 2026
Accepted: 12 October 2026
Published: 06 November 2026
DOI: https://doi.org/10.1038/s41598-026-76186-5
Keywords
来源:Nature 健康护理主题 · nature.com